Literature DB >> 18452649

Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro.

Shu-zhen Wang1, Xue-gang Luo, Jing Shen, Jia-ning Zou, Yun-hua Lu, Tao Xi.   

Abstract

Elevated expression of SMYD3 is a frequent genetic abnormality in several malignancies. Few studies knocking down SMYD3 expression in cervical carcinoma cells have been performed to date. In this paper, we established an inducible short hairpin RNA expression system to examine its role in maintaining the malignant phenotype of HeLa cells. After being induced by doxycycline, SMYD3 mRNA and protein expression were both reduced, and significant reductions in cell proliferation, colony formation and migration/invasion activity were observed in the SMYD3-silenced HeLa cells. The percentage of cells in sub-G1 was elevated and DNA ladder formation could be detected, indicating potent induction of apoptosis by SMYD3 knockdown. These findings imply that SMYD3 plays crucial roles in HeLa cell proliferation and migration/invasion, and that it may be a useful therapeutic target in human cervical carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452649     DOI: 10.5483/bmbrep.2008.41.4.294

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  26 in total

1.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

2.  Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.

Authors:  Chuhui Huang; Si Si Liew; Grace R Lin; Anders Poulsen; Melgious J Y Ang; Brian C S Chia; Sin Yin Chew; Zekui P Kwek; John L K Wee; Esther H Ong; Priya Retna; Nithya Baburajendran; Rong Li; Weixuan Yu; Xiaoying Koh-Stenta; Anna Ngo; Sravanthy Manesh; Justina Fulwood; Zhiyuan Ke; Hwa Hwa Chung; Sugunavathi Sepramaniam; Xin Hui Chew; Nurul Dinie; May Ann Lee; Yun Shan Chew; Choon Bing Low; Vishal Pendharkar; Vithya Manoharan; Susmitha Vuddagiri; Kanda Sangthongpitag; Joma Joy; Alex Matter; Jeffrey Hill; Thomas H Keller; Klement Foo
Journal:  ACS Med Chem Lett       Date:  2019-05-23       Impact factor: 4.345

3.  Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population.

Authors:  Virendra Singh; Laishram C Singh; Avninder P Singh; Jagannath Sharma; Bibhuti B Borthakur; Arundhati Debnath; Avdhesh K Rai; Rup K Phukan; Jagadish Mahanta; Amal C Kataki; Sujala Kapur; Sunita Saxena
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells.

Authors:  Qing-Qing Dong; Qiu-Tong Wang; Lei Wang; Ya-Xin Jiang; Mei-Ling Liu; Hai-Jie Hu; Yong Liu; Hao Zhou; Hong-Peng He; Tong-Cun Zhang; Xue-Gang Luo
Journal:  Food Sci Biotechnol       Date:  2018-03-22       Impact factor: 2.391

5.  Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.

Authors:  Dongju Chen; Lei Liu; Xuegang Luo; Ai Mu; Lihua Yan; Xiaoying Chen; Lei Wang; Nan Wang; Hongpeng He; Hao Zhou; Tongcun Zhang
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

6.  New marks on the block: Set5 methylates H4 lysines 5, 8 and 12.

Authors:  Erin M Green; Ashby J Morrison; Or Gozani
Journal:  Nucleus       Date:  2012-06-12       Impact factor: 4.197

7.  SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.

Authors:  Claudio Fenizia; Cinzia Bottino; Silvia Corbetta; Raffaella Fittipaldi; Pamela Floris; Germano Gaudenzi; Silvia Carra; Franco Cotelli; Giovanni Vitale; Giuseppina Caretti
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

Review 8.  SET and MYND domain containing protein 3 in cancer.

Authors:  Lei Huang; A-Man Xu
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

9.  Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.

Authors:  Yong Liu; Jingyu Deng; Xuegang Luo; Yuan Pan; Li Zhang; Rupeng Zhang; Han Liang
Journal:  Med Oncol       Date:  2014-12-04       Impact factor: 3.064

10.  Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.

Authors:  Krishna R Kalari; Scott J Hebbring; High Seng Chai; Liang Li; Jean-Pierre A Kocher; Liewei Wang; Richard M Weinshilboum
Journal:  BMC Genomics       Date:  2010-06-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.